151 related articles for article (PubMed ID: 9488130)
1. Do inflammatory processes contribute to radiation induced erythema observed in the skin of humans?
Simonen P; Hamilton C; Ferguson S; Ostwald P; O'Brien M; O'Brien P; Back M; Denham J
Radiother Oncol; 1998 Jan; 46(1):73-82. PubMed ID: 9488130
[TBL] [Abstract][Full Text] [Related]
2. Underprediction of human skin erythema at low doses per fraction by the linear quadratic model.
Hamilton CS; Denham JW; O'Brien M; Ostwald P; Kron T; Wright S; Drr W
Radiother Oncol; 1996 Jul; 40(1):23-30. PubMed ID: 8844884
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the anti-inflammatory potential of Aloe vera gel (97.5%) in the ultraviolet erythema test.
Reuter J; Jocher A; Stump J; Grossjohann B; Franke G; Schempp CM
Skin Pharmacol Physiol; 2008; 21(2):106-10. PubMed ID: 18253066
[TBL] [Abstract][Full Text] [Related]
4. Ultraviolet B dose-dependent inflammation in humans: a reflectance spectroscopic and laser Doppler flowmetric study using topical pharmacologic antagonists on irradiated skin.
Andersen PH; Abrams K; Maibach H
Photodermatol Photoimmunol Photomed; 1992 Feb; 9(1):17-23. PubMed ID: 1390118
[TBL] [Abstract][Full Text] [Related]
5. Does aqueous or sucralfate cream affect the severity of erythematous radiation skin reactions? A randomised controlled trial.
Wells M; Macmillan M; Raab G; MacBride S; Bell N; MacKinnon K; MacDougall H; Samuel L; Munro A
Radiother Oncol; 2004 Nov; 73(2):153-62. PubMed ID: 15542162
[TBL] [Abstract][Full Text] [Related]
6. A quantitative study of the effect of topical indomethacin on cutaneous erythema induced by UVB and UVC radiation.
Farr PM; Diffey BL
Br J Dermatol; 1986 Oct; 115(4):453-66. PubMed ID: 3778814
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the inhibitory activity of topical indomethacin, betamethasone valerate and emollients on UVL-induced inflammation by means of non-invasive measurements of the skin elasticity.
Dobrev H
Photodermatol Photoimmunol Photomed; 2001 Aug; 17(4):184-8. PubMed ID: 11499541
[TBL] [Abstract][Full Text] [Related]
8. The UV erythema test as a model to investigate the anti-inflammatory potency of topical preparations--reevaluation and optimization of the method.
Jocher A; Kessler S; Hornstein S; Schulte Mönting J; Schempp CM
Skin Pharmacol Physiol; 2005; 18(5):234-40. PubMed ID: 16015022
[TBL] [Abstract][Full Text] [Related]
9. UV-induced erythema model: a tool in dermatopharmacology for testing the topical activity of non-steroidal anti-inflammatory agents in man.
Torrent J; Izquierdo I; Barbanoj MJ; Moreno J; Lauroba J; Jané F
Methods Find Exp Clin Pharmacol; 1988 May; 10(5):341-5. PubMed ID: 3398651
[TBL] [Abstract][Full Text] [Related]
10. UVB erythema inhibited by topically applied substances.
Väänänen A; Hannuksela M
Acta Derm Venereol; 1989; 69(1):12-7. PubMed ID: 2563602
[TBL] [Abstract][Full Text] [Related]
11. Induction of p53 expression in skin by radiotherapy and UV radiation: a randomized study.
Ponten F; Lindman H; Bostrom A; Berne B; Bergh J
J Natl Cancer Inst; 2001 Jan; 93(2):128-33. PubMed ID: 11208882
[TBL] [Abstract][Full Text] [Related]
12. Intensity and area increase of UVB-induced erythema: two variables used for studies of the influence of topically applied drugs.
Juhlin L; Shroot B
Acta Derm Venereol; 1993 Aug; 73(4):273-5. PubMed ID: 7904100
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing the degree of erythematous skin reactions in humans.
Denham JW; Hamilton CS; Simpson SA; Ostwald PM; O'Brien M; Kron T; Joseph DJ; Dear KB
Radiother Oncol; 1995 Aug; 36(2):107-20. PubMed ID: 7501808
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory effects of topical formulations containing sea silt and sea salt on human skin in vivo during cutaneous microdialysis.
Quist SR; Wiswedel I; Quist J; Gollnick HP
Acta Derm Venereol; 2011 Sep; 91(5):597-9. PubMed ID: 21597673
[No Abstract] [Full Text] [Related]
15. Delay of erythema of human skin by anti-inflammatory drugs after ultraviolet irradiation.
Gruber CM; Ridolfo AS; Nickander R; Mikulaschek WM
Clin Pharmacol Ther; 1972; 13(1):109-13. PubMed ID: 5008187
[No Abstract] [Full Text] [Related]
16. Quantification of patient to patient variation of skin erythema developing as a response to radiotherapy.
Russell NS; Knaken H; Bruinvis IA; Hart AA; Begg AC; Lebesque JV
Radiother Oncol; 1994 Mar; 30(3):213-21. PubMed ID: 8209004
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of topical steroids in the control of radiation dermatitis: a randomised trial using 1% hydrocortisone cream and 0.05% clobetasone butyrate (Eumovate).
Glees JP; Mameghan-Zadeh H; Sparkes CG
Clin Radiol; 1979 Jul; 30(4):397-403. PubMed ID: 380872
[TBL] [Abstract][Full Text] [Related]
18. The degrees of UVB-induced erythema and pigmentation correlate linearly and are reduced in a parallel manner by topical anti-inflammatory agents.
Takiwaki H; Shirai S; Kohno H; Soh H; Arase S
J Invest Dermatol; 1994 Nov; 103(5):642-6. PubMed ID: 7963648
[TBL] [Abstract][Full Text] [Related]
19. Effect of topical diflumidone on ultraviolet-light-induced erythema.
Gomez EC; Trancik RJ
Dermatologica; 1981; 162(3):175-82. PubMed ID: 7250461
[TBL] [Abstract][Full Text] [Related]
20. Does the interval between fractions matter in the range of 4-8 h in radiotherapy? A study of acute and late human skin reactions.
Nyman J; Turesson I
Radiother Oncol; 1995 Mar; 34(3):171-8. PubMed ID: 7631023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
